Octagen Corporation
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII (NCT00245245) | Octagen Corporation | 2005-05-01 |
Track Octagen Corporation automatically
Every clearance here is in the API, with alerts when new ones post.